ARCHIVES

ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

Farber Grant Probe Misses Real Story

July 8, 1977

Non-Chemo Agents Added To Regimens For Lymphomas

January 26, 2007

Mail Mixup Delays July 23 Issue

August 6, 1976

Goodfellow To Lead Gynecologic Oncology Research Team At Ohio State University

January 11, 2013

Learning From Europeans, U.S. Oncologists Consider Role For Oxaliplatin, 5-FU Infusion

May 31, 2002

Leffall New ACS President, Gudberg, President-Elect

November 17, 1978